Farshad Guirakhoo PhD

Dr. Farshad Guirakhoo serves as Chief Scientific Officer at Vaxxinity, the company formerly known as United Neuroscience (UNS, a subsidiary of UBI), and COVAXX, overseeing all RD projects for developing vaccines against infectious diseases and CNS using a proprietary “Endobody” vaccine platform. Dr. Guirakhoo was named in 2014 as no. 22 in the list of the 50 Most Influential People in Vaccines.

Dr. Guirakhoo is the author of over 100 peer-reviewed publications, including book chapters, and holds dozen patents. Dr. Guirakhoo received his Ph.D. in Virology from the University of Vienna, Austria, holds an M.Sc. in Genetics, and a B.Sc. in Biology. He has been awarded the National Research Council Post-Doctorate Award and studied at the National Centers for Disease Control (CDC), Division of Vector-Borne Infectious Diseases (DVBID), in Fort Collins, CO.